Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) Administered with Routine Pediatric Vaccines: A European Randomized Controlled Trial.
Saved in:
| Title: | Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) Administered with Routine Pediatric Vaccines: A European Randomized Controlled Trial. |
|---|---|
| Authors: | Martinon-Torres F; Translational Paediatrics and Infectious Diseases Section, Paediatrics Department, Hospital Clínico Universitario de Santiago de Compostela, 15701, Santiago de Compostela, Spain.; Genetics, Vaccines, and Infections Research Group (GENVIP), Healthcare Research Institute of Santiago de Compostela, University of Santiago de Compostela, 15701, Santiago de Compostela, Spain.; CIBER of Respiratory Diseases (CIBERES), Instituto de Salud Carlos III, 28222, Madrid, Spain., Virta MM; Finnish Vaccine Research, Järvenpää Clinic, Mannilantie, Järvenpää, Finland., Koski S; Finnish Vaccine Research, Helsinki South Clinic, Vuorikatu, Helsinki, Finland.; Finnish Vaccine Research, Helsinki East Clinic, Itäkeskuksen Kauppakeskus, Agenttitalo, Turunlinnantie, Helsinki, Finland., de la Cueva IS; Unidad de Investigación, Grupo IHP (Instituto Hispalense de Pediatría), Seville, Spain., Szymanski HT; Department of Pediatrics, Szpital im. Swietej Jadwigi Slaskiej w Trzebnicy, Prusicka 53-55, 55-100, Trzebnica, Poland., Bosis S; Pneumology and Infectious Diseases Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., Drăgănescu AC; National Institute for Infectious Diseases 'Prof. Dr. Matei Bals', Bucharest, Romania.; Department of Pediatrics, Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania., Silfverdal SA; Clinical Sciences, Pediatrics, Umeå University, Umeå, Sweden., Zambrano B; Global Clinical Development Strategy, Sanofi, Montevideo, Uruguay., Dhingra MS; Global Clinical Development Strategy, Sanofi, Swiftwater, PA, USA., B'Chir S; Global Biostatistical Sciences, Sanofi, Marcy L'Étoile, France., Syrkina O; Patient Safety and Pharmacovigilance, Sanofi R&D, Cambridge, MA, USA., Lyabis O; Global Clinical Development Strategy, Sanofi, Marcy L'Étoile, France., Vasquez GA; Global Clinical Development Strategy, Sanofi, Swiftwater, PA, USA. gustavo.vasquez@sanofi.com., Rehm C; Global Clinical Development Strategy, Sanofi, Swiftwater, PA, USA. |
| Corporate Authors: | MET58 Study Group |
| Source: | Infectious diseases and therapy [Infect Dis Ther] 2025 Aug; Vol. 14 (8), pp. 1843-1865. Date of Electronic Publication: 2025 Jul 15. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Adis Country of Publication: New Zealand NLM ID: 101634499 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2193-8229 (Print) Linking ISSN: 21936382 NLM ISO Abbreviation: Infect Dis Ther Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
